Lessi, F.; Laurino, M.; Papayannidis, C.; Vitagliano, O.; Grimaldi, F.; Lazzarotto, D.; Gottardi, M.; Crisà , E.; Riva, M.; Reda, G.;
et al. Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study. Biomedicines 2021, 9, 972.
https://doi.org/10.3390/biomedicines9080972
AMA Style
Lessi F, Laurino M, Papayannidis C, Vitagliano O, Grimaldi F, Lazzarotto D, Gottardi M, Crisà E, Riva M, Reda G,
et al. Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study. Biomedicines. 2021; 9(8):972.
https://doi.org/10.3390/biomedicines9080972
Chicago/Turabian Style
Lessi, Federica, Marica Laurino, Cristina Papayannidis, Orsola Vitagliano, Francesco Grimaldi, Davide Lazzarotto, Michele Gottardi, Elena Crisà , Marta Riva, Gianluigi Reda,
and et al. 2021. "Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study" Biomedicines 9, no. 8: 972.
https://doi.org/10.3390/biomedicines9080972
APA Style
Lessi, F., Laurino, M., Papayannidis, C., Vitagliano, O., Grimaldi, F., Lazzarotto, D., Gottardi, M., Crisà , E., Riva, M., Reda, G., Ermani, M., Semenzato, G., Trentin, L., & Ferrara, F.
(2021). Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study. Biomedicines, 9(8), 972.
https://doi.org/10.3390/biomedicines9080972
